Sen. Bill Cassidy (R-LA) questioned whether Dr. Erica Schwartz, Trump’s nominee for CDC Director, will change the agency's vaccine website language regarding autism [1].
The issue centers on whether the CDC's public guidance projects uncertainty about a link between vaccines and autism. Because the website serves as a primary source of public health information, any modification to its language on vaccine safety could signal a shift in federal scientific communication.
Cassidy has used the website's wording as a barometer for the nominee's stance on vaccine safety. In a recent interview on July 26 [1], the senator said the potential for removing language that implies a possible link between vaccines and autism was a concern.
Reports on the current status of the website are contradictory. According to a report from The Hill, the Department of Health and Human Services had modified the CDC's website on vaccines and autism as a sign of good faith [2]. Similarly, a July 23 report from CNN said that a vote on the nominee was clinched with a change to the site [3].
However, a separate CNN video interview on July 26 suggested the CDC has yet to remove the language projecting uncertainty [1]. This discrepancy leaves the exact state of the public-facing guidance unclear as the confirmation process continues.
Dr. Schwartz has previously addressed concerns regarding her commitment to scientific integrity. During a Senate hearing on July 15, Schwartz said, "I will never betray the science" [4].
The Senate Health, Education, Labor, and Pensions Committee held a vote on the nominee on July 23 [3]. Cassidy's focus on the website suggests that the removal of ambiguous language remains a key point of leverage in the nomination process [2].
“"I will never betray the science."”
The dispute over a few lines of text on a government website reflects a larger political struggle over the perceived independence of the CDC. By linking the nominee's confirmation to specific wording about vaccines and autism, lawmakers are attempting to codify a commitment to established scientific consensus before the new director takes office.
